Cite
HARVARD Citation
Serin, I. et al. (n.d.). 000448 UTILIZABILITY OF THE SERUM IGF-1, IGFBP-3, LEPTIN AND CA-125 LEVELS IN BENIGN-MALIGN DIFFERENTIATION IN PATIENTS WITH OVARIAN TUMORS. International journal of gynecological cancer. p. 175. [Online].